Antiemetic Use Among Pregnant Women in the United States: The Escalating Use of Ondansetron

    Basic Details
    Date
    Monday, February 20, 2017
    Type
    Publication
    Description

    This report examines ondansetron use in pregnancy in the context of other antiemetic use among a large insured United States population of women delivering live births.

    Author(s)

    Lockwood G. Taylor PhD, MPH; Steven T. Bird PharmD, PhD, MS; Leyla Sahin MD; Melissa S. Tassinari PhD; Patty Greene PharmD; Marsha E. Reichman PhD; Susan E. Andrade ScD; Katherine Haffenreffer BS; Sengwee Toh ScD

    Corresponding Author

    L. G. Taylor, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Bldg 22, Rm 2406, Silver Spring, MD 20903, USA. E-mail: lockwood.taylor@fda.hhs.gov